Schengrund C L, Repman M A, Shochat S J
Cancer. 1985 Dec 1;56(11):2640-6. doi: 10.1002/1097-0142(19851201)56:11<2640::aid-cncr2820561118>3.0.co;2-w.
The ganglioside composition of neuroblastoma samples from 53 patients was determined. Tumor sites included the adrenals (15), and the thoracic (20), abdominal (15), and pelvic (3) areas. Age of the patients at the time of surgery ranged from 1 day to over 10 years and the Stage of the tumors from A to D. Differences in ganglioside patterns were observed, with neuroblastomas from patients who were either disease positive or dead of disease tending to have more monosialogangliosides and fewer gangliotetraose gangliosides of the B series (formula; see text) than tumors from patients who were disease-free. More specifically, six of the seven patients lacking GT1b died of disease, suggesting that the absence of GT1b is indicative of a poor prognosis.
测定了53例神经母细胞瘤患者样本的神经节苷脂组成。肿瘤部位包括肾上腺(15例)、胸部(20例)、腹部(15例)和盆腔(3例)区域。手术时患者年龄从1天到10岁以上不等,肿瘤分期从A到D。观察到神经节苷脂模式存在差异,疾病阳性或死于疾病的患者的神经母细胞瘤往往比无病患者的肿瘤具有更多的单唾液酸神经节苷脂和更少的B系列神经节四糖神经节苷脂(分子式;见正文)。更具体地说,7例缺乏GT1b的患者中有6例死于疾病,这表明缺乏GT1b预示着预后不良。